GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Capital Expenditure

Hanmi Pharm Co (XKRX:128940) Capital Expenditure : ₩-60,641.60 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Hanmi Pharm Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-13,175 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-60,641.60 Mil.

Hanmi Pharm Co Capital Expenditure Historical Data

The historical data trend for Hanmi Pharm Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co Capital Expenditure Chart

Hanmi Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57,839.48 -34,424.93 -49,593.08 -43,736.29 -62,554.42

Hanmi Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15,088.29 -14,432.63 -11,507.94 -21,525.57 -13,175.46

Hanmi Pharm Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-60,641.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hanmi Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Capital Expenditure
Comparable Companies
XKRX:000250 XKRX:068760 XKRX:069620 XKRX:237690 XKRX:006280 XKRX:009420 XKRX:195940 XKRX:185750 XKRX:003090 XKRX:086450 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724
Website
http://www.hanmi.co.kr
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines